A carregar...
Bevacizumab in the treatment of NSCLC: patient selection and perspectives
Non-small-cell lung cancer (NSCLC) represents about 85% of all lung cancers, and more than half of NSCLCs are diagnosed at an advanced stage. Chemotherapy has reached a plateau in the overall survival curve of about 10 months. Therefore, in last decade novel targeted approaches have been developed t...
Na minha lista:
| Publicado no: | Lung Cancer (Auckl) |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5733913/ https://ncbi.nlm.nih.gov/pubmed/29276417 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/LCTT.S110306 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|